Skip to the page

Data / Form D filings / Xsphera Biosciences Inc

Xsphera Biosciences Inc: Form D filings

Xsphera Biosciences Inc, a biotechnology company in Boston, MA, filed 2 Form D notices with the SEC between 2022 and 2023. The latest, on May 4, 2023, reports $12.6 million sold of a $19.9 million offering to 40 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
6 TIDE STREET, Boston, MA, 02110
Phone
(617) 832-3030
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2018
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1934197

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 4, 2023New notice$19,899,952$12,600,067$7,299,88540Apr 24, 2023sec.gov
Jun 16, 2022New notice$3,000,000$100,000$2,900,0001May 31, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Stephen RemondiExecutive Officer, Director
Robert WalshDirector

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of May 1, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Xsphera Biosciences Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.